Recombinant tissue plasminogen activator (rt-PA) utilisation by rural clinicians in acute ischaemic stroke: A survey of barriers and enablers

Australian Journal of Rural Health

Volumn 21, Issue 5, 2013, Pages 262-267

  Williams, Jocelyn M ^a   Jude, Martin R ^d   Levi, Christopher R ^b,c  

^a Wagga Wagga Base Hospital   (Australia)

^b UNIVERSITY OF NEWCASTLE   (Australia)

^c HUNTER MEDICAL RESEARCH INSTITUTE   (Australia)

^d UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Decision making; Emergency medicine; Obstacle; Physician; Thrombolytic therapy

Indexed keywords

TISSUE PLASMINOGEN ACTIVATOR;

ADULT; ARTICLE; AUSTRALIA; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CLINICAL PRACTICE; DECISION MAKING; DRUG UTILIZATION; EMERGENCY MEDICINE; FIBRINOLYTIC THERAPY; HEALTH CARE SURVEY; HUMAN; OBSTACLE; PHYSICIAN; STATISTICS;

DECISION MAKING; EMERGENCY MEDICINE; OBSTACLE; PHYSICIAN; THROMBOLYTIC THERAPY;

ADULT; BRAIN ISCHEMIA; DECISION MAKING; DRUG UTILIZATION; HEALTH CARE SURVEYS; HUMANS; NEW SOUTH WALES; PHYSICIAN'S PRACTICE PATTERNS; STROKE; TISSUE PLASMINOGEN ACTIVATOR;

EID: 84885455344     PISSN: 10385282     EISSN: 14401584     Source Type: Journal    
DOI: 10.1111/ajr.12052     Document Type: Article

References (24)

1. Australian Institute of Health and Welfare. Australia's Health. AIHW cat. No. AUS 73. Canberra: AIHW, 2006.
2. Wardlaw JM, Zoppo G, Yamaguchi T, Berge E. Thrombolysis for acute ischaemic stroke (Review). Cochrane Database of Systematic Reviews 2009; 4: CD000213.
3. Boode B, Welzen V, Franke C, Van Oostenbrugge R. Estimating the number of stroke patients eligible for thrombolytic treatment if delay could be avoided. Cerebrovascular Diseases 2006; 23: 294-298.
4. National Stroke Foundation. National Stroke Audit - Acute Services Clinical Audit Report. Melbourne, Australia: National Stroke Foundation, 2011.
5. Quain DA, Parson MW, Loudfoot AR etal. Improving access to acute stroke therapies: a controlled trial of organised and pre hospital and emergency care. Medical Journal of Australia 2008; 189: 429-433.
6. Ad Hoc Committee representing the National Stroke Foundation and the Stroke Society of Australasia. The implementation of intravenous tissue plasminogen activator in acute ischaemic stroke - a scientific position statement from the National Stroke Foundation and the Stroke Society of Australasia, Position Statement. Internal Medicine Journal 2009; 39: 317-324.
7. Bray JE, Mosley I, Bailey M etal. Stroke public awareness campaigns have increased ambulance dispatches for stroke in Melbourne, Australia. Stroke 2011; 42: 2154-2157.
8. Leira E, Hess D, Torner J, Adams H. Rural-Urban differences in acute stroke management practices. Archives of Neurology 2008; 65: 887-891.
9. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. The New England Journal of Medicine 1995; 333: 1581-1587.
10. Australian and New Zealand Association of Neurologists. ANZAN Workforce Survey 2009. Sydney, NSW: Australian and New Zealand Association of Neurologists, 2010.
11. Eissa A, Krass I, Bajorek BV. Barriers to the utilization of thrombolysis for acute ischaemic stroke. Journal of Clinical Pharmacy and Therapeutics 2012; 37: 399-409.
12. Scott P, Xu Z, Meurer W etal. Attitudes and beliefs of Michigan emergency physicians toward tissue plasminogen activator use in stroke: baseline survey results from the Increasing Stroke Treatment through Interactive behavioural Change Tactic (INSTINCT) Trial Hospitals. Stroke 2010; 41: 2026-2032.
13. Bruins Slot K, Murray V, Boysen G, Berge E. Thrombolytic treatment for stroke in the Scandinavian countries. Acta Neurologica Scandinavica 2009; 120: 270-275.
14. Brown DL, Barsan WG, Lisabeth LD, Gallery ME, Morgenstern LB. Survey of emergency physicians about recombinant tissue plasminogen activator for acute ischaemic stroke. Ann Emergency Med 2005; 46: 56-60.
15. Bambaue K, Johnston C, Bambaue D, Zivin J. Reasons why few patients with acute stroke receive tissue plasminogen activator. Arch Neurology 2006; 63: 661-664.
16. Johnson M, Bakas T. A review of barriers to thrombolytic therapy: implications for nursing care in the emergency department. Neuroscience Nursing 2010; 42: 88-94.
17. Edwards PJ, Roberts I, Clarke MJ etal. Methods to increase response to postal and electronic questionnaires. Cochrane Database of Systematic Reviews 2009; 3: MR000008.
18. National Stroke Foundation. Clinical Guidelines for Acute Stroke Management. Melbourne, Australia: National Stroke Foundation, 2007.
19. MacDonald E, Newburn-Cook C, Schopflocher D, Richter S. Addressing non-response bias in postal surveys. Public Health Nursing 2009; 26: 95-105.
20. Lin CB, Peterson ED, Smith EE etal. Emergence medical service hospital prenotification is associated with improved evaluation and treatment of acute ischemic stroke. Circ Cardiovascular Qual Outcomes 2010; 5: 514-522.
21. Kwan J, Hand P, Sandercock P. A systematic review of barriers to delivery of thrombolysis for acute stroke. Age and Ageing 2004; 33: 116-121.
22. Nagao K, Koschel A, Haines H, Bolitho L, Yan B. Rural Victorian telestroke project. Internal Medicine Journal 2011; 42: 1088-1095.
23. National Stroke Foundation. Clinical Guidelines for Acute Stroke Management. Melbourne, Australia: National Stroke Foundation, 2010.
24. Tai YJ, Weir P, Hand P etal. Does a 'code stroke' rapid access protocol decrease door-to-needle time for thrombolysis? Internal Medicine Journal 2012; 42: 1316-1324.